Mild antagonistic effect of Valproic acid in combination with AZD2461 in MCF-7 breast cancer cells.

Sargazi, Saman; Kooshkaki, Omid; Zavar Reza, Javad; Saravani, Ramin; Zarei Jaliani, Hossein; Mirinejad, Shekoufeh; Meshkini, Fatemeh

Sargazi, Saman; Kooshkaki, Omid; Zavar Reza, Javad; Saravani, Ramin; Zarei Jaliani, Hossein; Mirinejad, Shekoufeh; Meshkini, Fatemeh.

Afiliação

Sargazi S; Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Kooshkaki O; Department of Immunology, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Zavar Reza J; Department of Clinical Biochemistry, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Saravani R; Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Zarei Jaliani H; Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
Mirinejad S; Protein Engineering Laboratory, Department of Medical Genetics, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Meshkini F; Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.

Med J Islam Repub Iran ; 33: 29, 2019.

Article em En | MEDLINE | ID: mdl-31380319

Palavras-chave

AZD2461; Breast cancer; Combination therapy; Valproic acid

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Med J Islam Repub Iran Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Irã

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google